The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
A Role for iNOS in Fasting Hyperglycemia and Impaired Insulin Signaling in the Liver of Obese Diabetic Mice
Open accessAbstract
Chronic inflammation has been postulated to play an important role in the pathogenesis of insulin resistance. Inducible nitric oxide synthase (iNOS) has been implicated in many human diseases associated with inflammation. iNOS deficiency was shown to prevent high-fat diet-induced insulin resistance in skeletal muscle but not in the liver. A role for iNOS in fasting hyperglycemia and hepatic insulin resistance, however, remains to be investigated in obesity-related diabetes. To address this issue, we examined the effects of a specific inhibitor for iNOS, L-NIL, in obese diabetic (ob/ob) mice. iNOS expression was increased in the liver of ob/ob mice compared with wild-type mice. Treatment with iNOS inhibitor reversed fasting hyperglycemia with concomitant amelioration of hyperinsulinemia and improved insulin sensitivity in ob/ob mice. iNOS inhibitor also increased the protein expression of insulin receptor substrate (IRS)-1 and -2 1.5- and 2-fold, respectively, and enhanced IRS-1- and IRS-2-mediated insulin signaling in the liver of ob/ob mice. Exposure to NO donor and ectopically expressed iNOS decreased the protein expression of IRS-1 and -2 in cultured hepatocytes. These results suggest that iNOS plays a role in fasting hyperglycemia and contributes to hepatic insulin resistance in ob/ob mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and the use of an NOS2-specific inhibitor (L-NIL) reversed hyperglycemia, hyperinsulinemia, and insulin resistance in ob/ob mice [150].”
From Regulation of obesity and insulin resistance by nitric oxide (2014) · cites this paper as [150]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.
Xie, Q. W., Kashiwabara, Y., & Nathan, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37600-7 · Cited by 2,212 · cited 2×
“Inducible nitric oxide synthase (iNOS; also termed NOS2), whose expression is regulated by IKK –NF- B (6), is assumed to be one of the candidates that mediate inflammation-involved insulin resistance.”
Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Michael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296
Lipotoxic heart disease in obese rats: Implications for human obesity
Zhou, Y.-T., Grayburn, P., Karim, A., Shimabukuro, M., Higa, M., Baetens, D., Orci, L., & Unger, R. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1784 · Cited by 1,265
Muscle‐derived interleukin‐6: mechanisms for activation and possible biological roles
FEBBRAIO, M. A., & PEDERSEN, B. K. (2002) · The FASEB Journal · doi:10.1096/fj.01-0876rev · Cited by 875
Shimomura, I., Matsuda, M., Hammer, R. E., Bashmakov, Y. K., Brown, M. S., & Goldstein, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00010-9 · Cited by 860
Blüher, M., Michael, M. D., Peroni, O. D., Ueki, K., Carter, N., Kahn, B. B., & Kahn, C. R. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00199-5 · Cited by 806
Prevention of fat-induced insulin resistance by salicylate
Kim, J. K., Kim, Y.-J., Fillmore, J. J., Chen, Y., Moore, I., Lee, J., Yuan, M., Li, Z. W., Karin, M., Perret, P., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11559 · Cited by 737
Potential Role of TNF-α in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Moller, D. E. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00272-1 · Cited by 730
New Perspectives into the Molecular Pathogenesis and Treatment of Type 2 Diabetes
Saltiel, A. R. (2001) · Cell · doi:10.1016/s0092-8674(01)00239-2 · Cited by 688
Cited by
Sorted by citations
Items 101–200 of 208
ADH5-mediated NO bioactivity maintains metabolic homeostasis in brown adipose tissue
Sebag, S. C., Zhang, Z., Qian, Q., Li, M., Zhu, Z., Harata, M., Li, W., Zingman, L. V., Liu, L., Lira, V. A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110003 · Cited by 28
“Previous studies investigating the modulation of nitrosative signaling in the adipose tissue have involved deletion or inhibition of NOS expression and activity (Becerril et al., 2018; Fujimoto et al., 2005; Tsuchiya et al., 2007; Zanotto et al., 2016), thereby diminishing all forms of NO bioactivity while also impair…”
Wójcik, M., Zieleniak, A., Żurawska-Kliś, M., Cypryk, K., & Woźniak, L. A. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215615699 · Cited by 26
“It is of note that several studies have reported iNOS overexpression in metabolic tissues of both dietary and genetic models of obesity.(27,28) However, since no significant differences in BMI and body weight gain occur between the GDM and NGT groups in our study, we can exclude the possibility lipid-induced alteratio…”
Takatani, N., Taya, D., Katsuki, A., Beppu, F., Yamano, Y., Wada, A., Miyashita, K., & Hosokawa, M. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000405 · Cited by 25
Rocha, S., Corvo, M. L., Freitas, M., & Fernandes, E. G. R. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124441 · Cited by 26
Yano, H., Sakai, M., Matsukawa, T., Yagi, T., Naganuma, T., Mitsushima, M., Iida, S., Inaba, Y., Inoue, H., Unoki‐Kubota, H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-32575-z · Cited by 22
Parveen, K., Ishrat, T., Malik, S., Kausar, M. A., & Siddiqui, W. A. (2012) · PROTOPLASMA · doi:10.1007/s00709-012-0418-2 · Cited by 24
Zhang, X., Huang, B., Zhou, X., & Chen, C. (2010) · Protein & Cell · doi:10.1007/s13238-010-0087-x · Cited by 23
“© Higher Education Press and Springer-Verlag Berlin Heidelberg 2010 675 et al., 2002; Fujimoto et al., 2005) and its complications (Ceriello et al., 2002), and alterations in the amount of Snitrosated proteins such as insulin receptors, insulin receptor substrate 1, and Akt (Carvalho-Filho et al.,…”
BackgroundBae, S.-K., Cha, H.-N., Ju, T.-J., Kim, Y., Kim, H. S., Kim, Y., Dan, J., Kim, J., Kim, S.-D., & Park, S. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00431.2011 · Cited by 23
“Although the expression level of iNOS is very low in skeletal muscle of normal rodent and human (14), overproduction of NO by elevated iNOS expression may be involved in muscle atrophy.”
Rimonabant Improves Oxidative/Nitrosative Stress in Mice with Nonalcoholic Fatty Liver Disease
Jorgačević, B. Z., Mladenović, D. R., Ninković, M., Vesković, M. N., Dragutinović, V. V., Vatazević, A., Vučević, D. B., Ješić-Vukićević, R., & Radosavljević, T. S. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/842108 · Cited by 22
Lu, M. M., Li, P., Pferdekamper, J., Fan, W., Saberi, M., Schenk, S., & Olefsky, J. M. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0462 · Cited by 21
“L-NIL treatment enhances IRS-1 and -2 levels and reduces fasting glucose in these animals (10).”
BackgroundInfluentialLima‐Cabello, E., Morales, S., Foley, R. C., Melser, S., Alché, V., Siddique, K. H. M., Singh, K. B., Ramírez, J. D. D. A., & Jiménez-López, J. C. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.11.040 · Cited by 28
Mechanisms of action of ginger in nuclear factor-kappaB signaling pathways in diabetes
Saedisomeolia, A., Arzati, M. M., Abdolahi, M., Sedighiyan, M., Rangel, A., Muench, G. W., Zarezadeh, M., Jafarieh, A., & Honarvar, N. M. (2018) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2018.10.004 · Cited by 21
Verma, S., Alam, R., Ahmad, I., Singla, D., Ali, K., & Hussain, M. E. (2018) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-018-0354-6 · Cited by 20
Hyperbaric Oxygen Therapy and Vascular Complications in Diabetes Mellitus
Resanović, I., Zarić, B. L., Radovanović, J., Sudar-Milovanovic, E. M., Gluvic, Z. M., Jevremović, D., & Isenović, E. R. (2020) · Angiology · doi:10.1177/0003319720936925 · Cited by 20
“Chronic hyperglycemia is linked with the abnormal synthesis of nitric oxide (NO), which is associated with DM-related vascular complications.(108,109) Hyperbaric oxygen therapy can differently regulate the synthesis of NO in patients with DM and vascular complications by affecting the activity of NO synthase (NOS).”
BackgroundPorojan, M. D., Catana, A. M., Popp, R. A., Dumitrascu, D. L., & Bala, C. G. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s93172 · Cited by 20
“Also, chronic inflammation has been proposed to be involved in the pathogenesis of obesity-related insulin resistance and type 2 diabetes, 29 and also a new study has shown that iNOS plays an important role in the pathogenesis of insulin resistance in vivo.”
Influence of a High-Fat Diet on Cardiac iNOS in Female Rats
Jovanović, A., Sudar-Milovanovic, E. M., Obradovic, M. M., Pitt, S. J., Stewart, A. J., Zafirovic, S. S., Stanimirović, J., Radak, D. J., & Isenović, E. R. (2016) · Current Vascular Pharmacology · doi:10.2174/1570161114666161025101303 · Cited by 20
“and they include the up-regulation of cardiac iNOS expression by a mechanism involving Akt and NFκB [17,19,20,49], and this may be the first step in the development of CVD.”
BackgroundInfluentialResanović, I., Gluvic, Z. M., Zarić, B. L., Sudar-Milovanovic, E. M., Jovanović, A., Milacic, D., Isaković, R., & Isenović, E. R. (2019) · International Journal of Endocrinology · doi:10.1155/2019/2328505 · Cited by 19
Wei, H., Deng, Z., Jiang, S., Song, T., Zhou, Y., Peng, J., & Tao, Y. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.10.029 · Cited by 21
Hwang, J.-H., Moon, S. A., Lee, C. H., Byun, M. R., Kim, A. R., Sung, M., Park, H., Hwang, E. S., Sung, S. H., & Hong, J. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.04.018 · Cited by 19
Costa, D. E. F. D. R., Silveira, A. L. M., Campos, G. P., Nóbrega, N. R. C., de Araújo, N. F., Borges, L. D. F., Capettini, L. D. S. A., Ferreira, A. V. M., & Bonaventura, D. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.628101 · Cited by 19
Becerril, S., Rodrı́guez, A., Catalán, V., Sáinź, N., Ramírez, B., Gómez‐Ambrosi, J., & Frühbeck, G. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00039.2012 · Cited by 18
“iNOS-knockout mice are protected from developing obesity and insulin resistance induced by high-fat feeding (32, 51).”
BackgroundResultAggarwal, H., Pathak, P., Singh, P., Gayen, J. R., Jagavelu, K., & Dikshit, M. (2020) · Antioxidants · doi:10.3390/antiox9080736 · Cited by 17
“Likewise, iNOS inhibition reversed hepatic IR and hyperglycemia in obese diabetic mice [34].”
BackgroundKakimoto, P. A., Chausse, B., da Silva, C. C. C., Donato, J., & Kowaltowski, A. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211733 · Cited by 19
Plasma heat shock protein response to euglycemia in type 2 diabetes
Atkin, A. S., Moin, A. S. M., Al‐Qaissi, A., Sathyapalan, T., Atkin, S. L., & Butler, A. E. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-002057 · Cited by 17
He, B., Zhao, S., Zhang, W., Li, Y., Lü, Y., & Han, P. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.04.004 · Cited by 17
Tirosh, O., Artan, A., Aharoni-Simon, M., Ramadori, G. P., & Madar, Z. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2789 · Cited by 17
“Treatment with iNOS inhibitors reversed LPS-induced fasting hyperglycemia with concomitant amelioration of hyperinsulinemia and improved insulin sensitivity (9, 33).”
Kadiiska, M. B., Bonini, M. G., Ruggiero, C., Cleland, E., Wicks, S. E., & Stadler, K. (2012) · Diabetes · doi:10.2337/db11-1091 · Cited by 16
Involvement of Cytokines in the Pathogenesis of Salt and Water Imbalance in Congestive Heart Failure
Azzam, Z. S., Kinaneh, S., Bahouth, F., Ismael-Badarneh, R., Khoury, E. E., & Abassi, Z. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00716 · Cited by 16
“It has been shown that iNOS has been implicated in many human diseases associated with inflammation via the activa tion of the cJNK, p42/44 MAPK, and p38 kinase pathways (130, 131).”
BackgroundSturzeneker, M. C. S., de Noronha, L., Olandoski, M., Wendling, L. U., & Précoma, D. B. (2019) · Europe PMC (PubMed Central) · Cited by 16
Antidiabetic Effects of Genistein: Mechanism of Action
Oshaghi, E. A., & Khodadadi, I. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666230516103420 · Cited by 15
Villagarcía, H. G., Castro, M. C., Arbeláez, L. F. G., Schinella, G. R., Massa, M. L., Spinedi, E., & Francini, F. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.03.008 · Cited by 15
Vilela, V. R., Samson, N., Nachbar, R. T., Perazza, L. R., Lachance, G., Rokatoarivelo, V., Centeno-Baez, C., Zancan, P., Sola‐Penna, M., Bellmann, K., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101437 · Cited by 17
“T NOS2 using L-NIL also improved fasting hyperglycemia and improved insulin sensitivity in obese diabetic ob/ob mice [18].”
BackgroundPatel, B., New, L. E., Griffiths, J. C., Deuchars, J., & Filippi, B. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101123 · Cited by 14
“iNOS is a marker of inflammation [56,57], where HFD-fed rodents exhibit higher levels of iNOS in muscle leading to insulin resistance [58].”
BackgroundIelciu, I., Filip, G. A., Sevastre-Berghian, A., Bâldea, I., Oláh, N.-K., BURTESCU, R. F., Toma, V. A., Moldovan, R., Oniga, I., & Hanganu, D. (2024) · Nutrients · doi:10.3390/nu17010158 · Cited by 16
“…is stimulated by proinflammatory cytokines, obesity, free fatty acids, hyperglycemia, endotoxins, or oxidative stress, can be identified in the pathologic conditions in various tissues such as skeletal muscle, adipose tissue, or liver [50,51], while NOS3 is identified in physiological conditions.”
Bashandy, S. A. E., Elbaset, M. A., Ibrahim, F. A. A., Abdelrahman, S. S. M., Moussa, S. A. A., & El‐Seidy, A. M. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-85794-6 · Cited by 14
Effects of altered hepatic lipid metabolism on regulation of hepatic iNOS
Stanimirović, J., Obradovic, M. M., Zafirovic, S. S., Resanović, I., Bogdanović, N., Gluvic, Z. M., Mousa, S. A., & Isenović, E. R. (2015) · Clinical Lipidology · doi:10.2217/clp.15.8 · Cited by 14
Martin, B., Caron, N., Jadot, I., Colombaro, V., Federici, G., Depommier, C., & Declèves, A. (2017) · Experimental Physiology · doi:10.1113/ep086594 · Cited by 14
“Similar data have been reported in rodent models of obesity or diabetes using L-NIL or L-NAME (a nonselective NOS inhibitor; Fujimoto et al. 2005; Tsuchiya et al. 2007).”
BackgroundMethodInfluentialS-adenosyl methionine protects ob/ob mice from CYP2E1-mediated liver injury
Dey, A., Caro, A. A., & Cederbaum, A. I. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00004.2007 · Cited by 14
“iNOS has been associated with the development of insulin resistance and impaired insulin signaling in the liver of obese mice (10).”
BackgroundRole of iNOS in Insulin Resistance and Endothelial Dysfunction
Aggarwal, H., Kanuri, B., & Dikshit, M. (2019) · Springer eBooks · doi:10.1007/978-981-13-8273-4_21 · Cited by 11
Özbayer, C., Değirmenci, İ., Kurt, H., Özden, H., Çivi, K., Başaran, A., & Güneş, H. V. (2011) · Turkiye Klinikleri Journal of Medical Sciences · doi:10.5336/medsci.2009-16216 · Cited by 12
Dietary L-arginine supplementation reduces fat mass in diet-induced obese rats
Jobgen, W. S. (2009) · OakTrust (Texas A&M University Libraries) · Cited by 12
Long-Term Exposure of Cultured Astrocytes to High Glucose Impact on Their LPS-Induced Activation
Abdyeva, A., Kurtova, E., Savinkova, I. G., Galkov, M., & Горбачева, Л. Р. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021122 · Cited by 12
Hussei, S. A., El-, O. M. A., & Hemdan, H. S. (2013) · International Journal of Biological Chemistry · doi:10.3923/ijbc.2014.21.36 · Cited by 11
“The role of iNOS in hyperglycemia and hepatic insulin resistance remains to be investigated (42).”
BackgroundLiu, C., Pan, X., Hao, Z., Wang, X., Wang, C., & Song, G. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12615 · Cited by 11
“The liver is essential for energy homeostasis and serves an active role in synthesis, storage and redistribution of glucose and free fatty acids (36).”
BackgroundZhong, L., Tran, T. A., Baguley, T. D., Lee, S. J., Henke, A., To, A., Li, S., Yu, S., Grieco, F. A., Roland, J. T., et al. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14388 · Cited by 9
“, 1992) and most dynamic in terms of response to cellular stress and has been shown to be a factor in models of type 1 diabetes and acute pancreatitis (Qader et al., 2003; Torres et al., 2004; Fujimoto et al., 2005; Muhammed et al., 2012).”
BackgroundTherapeutic Effect of Fucoxanthin on Metabolic Syndrome and Type 2 Diabetes
Miyashita, K., Nishikawa, S., & Hosokawa, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812019-4.00027-1 · Cited by 9
Panić, A., Stanimirović, J., Obradovic, M. M., Sudar-Milovanovic, E. M., Perović, M., Lačković, M., Petrović, N., & Isenović, E. R. (2018) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1680 · Cited by 9
Nitrosative Stress and Pathogenesis of Insulin Resistance
Kaneki, M., Shimizu, N., Yamada, D., & Chang, K. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.9.ft-17 · Cited by 9
Mohammad, S., Zoubi, S. A., Collotta, D., Krieg, N., Wissuwa, B., Alves, G. F., Purvis, G. S. D., Norata, G. D., Baragetti, A., Catapano, A. L., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.701275 · Cited by 7
“Indeed, iNOS is widely expressed in many insulin-sensitive tissues/organs including adipose tissue and liver (44).”
BackgroundRetractedTherapeutic Effect of Fucoxanthin on Metabolic Syndrome and Type 2 Diabetes
Miyashita, K., Nishikawa, S., & Hosokawa, M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385083-6.00029-2 · Cited by 8
Abo-Zaid, O. A., Moawed, F. S., Ismail, E. S., & Ahmed, E. S. A. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.113602 · Cited by 8
A New Treatment Strategy for Diabetic Dyslipidemia?
Kothari, V. M., & Bornfeldt, K. (2020) · Diabetes · doi:10.2337/dbi20-0035 · Cited by 8
“iNOS has been used as a secondary target for hybrid compounds because it is likely to play a critical role in insulin resistance, nonalcoholic fatty liver disease (NAFLD), and liver fibrosis (14,15).”
BackgroundÖzbayer, C., Kebapçı, M. N., Kurt, H., Çolak, E., Güneş, H. V., & Değirmenci, İ. (2021) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13471 · Cited by 7
Hepatic nNOS impaired hepatic insulin sensitivity through the activation of p38 MAPK
Zhao, T., Li, Q., Mao, Q., Mu, K., & Wang, C. (2021) · Journal of Endocrinology · doi:10.1530/joe-20-0322 · Cited by 6
Henriques, M. S. D. M., Leite, J. A., Diniz, M. D. F. F. M., & de Araújo, M. S. T. (2014) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.5935/1676-2444.20140007 · Cited by 6
“More recently, iNOS inhibition in mice also protected against the adverse effects associated with the high level of fat in states of insulin resistance((23)) and in genetically determined obesity models((13)).”
BackgroundParenteral Nutrition and Cardiotoxicity
van Nispen, J., Voigt, M., Song, E., Armstrong, A. T., Fedorova, M., Murali, V., Krebs, J., Samaddar, A., Manithody, C., & Jain, A. K. (2021) · Cardiovascular Toxicology · doi:10.1007/s12012-021-09638-1 · Cited by 5
Noh, J. S., Park, C. H., Tanaka, T., & Yokozawa, T. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.35.950 · Cited by 5
Plasma NOx Concentrations in Glucose Intolerance and Type 2 Diabetes
Binh, P. N. T., Abe, Y., Tien, P. G., Son, L. N. T. D., Hanh, T. T. M., Diep, D. T. N., Qui, L. T. K., Kawano, M., & Maruyama, C. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.7393 · Cited by 5
Mohamed (2010) · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology · doi:10.3844/ajbbsp.2010.204.212 · Cited by 5
“Inducible Nitric Oxide Synthase (iNOS; EC 1.14.13.39) is assumed to be one of the candidates that mediate inflammation involved in insulin resistance (Fujimoto et al., 2005).”
BackgroundInfluentialGhanem (2010) · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology · doi:10.3844/ajbbsp.2010.195.203 · Cited by 5
iNOS inhibits hair regeneration in obese diabetic (ob/ob) mice
Sasaki, M., Shinozaki, S., Morinaga, H., Kaneki, M., Nishimura, E. K., & Shimokado, K. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.071 · Cited by 4
Subramanian, S., Agrawal, S., Pallati, P. K., Sharma, P., Agrawal, D. K., & Nandipati, K. C. (2020) · Research Square · doi:10.21203/rs.3.rs-44070/v1 · Cited by 4
Youssef, E. A. (2016) · Journal of Bioscience and Applied Research/Journal of Bioscience and Applied Research · doi:10.21608/jbaar.2015.106489 · Cited by 3
“The induction of iNOS in the liver seemed to correlate with fatty changes and the expression of iNOS is up-regulated by most inducers of obesity, hyperglycemia, and insulin resistance, including free fatty acids, endotoxins, and oxidative stress (Fujimoto et al., 2005).”
BackgroundVascular Endothelial Dysfunction and Atherosclerosis: Role of Nitric Oxide System
Simo‐Cheyou, E. R., & Srivastava, A. K. (2015) · Springer eBooks · doi:10.1007/978-3-319-15961-4_26 · Cited by 4
“In fact, heightened levels of iNOS expression are observed in obese and diabetic states and account for aberrant PI3-K/ PKB signalling, insulin resistance and impaired endothelial function [ 98 – 100 ].”
BackgroundCaria, C. R. E. P., de Oliveira, C. C., Gotardo, É. M. F., de Souza, V. T., Rocha, T., Macedo, J. A., Carvalho, P. D. O., Ribeiro, M. L., & Gambero, A. (2014) · Food Research International · doi:10.1016/j.foodres.2014.02.025 · Cited by 3
Wójcik, M., Wessely‐Szponder, J., & Kosior‐Korzecka, U. (2014) · Polish Journal of Veterinary Sciences · doi:10.2478/pjvs-2014-0102 · Cited by 3
MOLECULAR MECHANISMS OF INSULIN RESISTANCE IN OBESITY
Marette, A. (2008) · Cited by 3
Rais, N., Parveen, K., Ahmad, R., Siddiqui, W. A., Nadeem, A., & Ved, A. (2022) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902022e201183 · Cited by 3
Souha, S. P., Mahmoudi, F., Noorizadeh, E., & Panahi, A. (2021) · International journal of basic science in medicine · doi:10.34172/ijbsm.2021.24 · Cited by 2
Therapeutic potential of orlistat - bupropion treatment on high fat diet-induced lipotoxicity
Hassanein, N. M. A., Elwy, A. E.-H. M., Tabl, G. A., & Al-Mallah, T. H. Y. (2015) · Toxicology and Environmental Health Sciences · doi:10.1007/s13530-015-0247-8 · Cited by 2
Potential Applications of Nitric Oxide Donors in Type 2 Diabetes
Bahadoran, Z., Mirmiran, P., Bahmani, M., & Ghasemi, A. (2022) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815079814122010018 · Cited by 2
Ibrahim, A. N., Mackawy, A. M. H., & Megahed, O. A. (2014) · Basic Sciences of Medicine · Cited by 1
Natural Antioxidants in Oxidative Stress‐Induced Diseases
Kalita, H., & Deb, P. K. (2022) · Wiley eBooks · doi:10.1002/9781119811794.ch1 · Cited by 2
Morsy, M., Khashaba, A., Agamy, A. I., & Eid, R. (2014) · American Journal of Applied Sciences · doi:10.3844/ajassp.2014.1087.1098 · Cited by 1
oxide synthase Obesity, insulin resistance, and skeletal muscle nitric
Pierce, J. R., Choi, M. D., Hickner, R. C., Kraus, R. M., Houmard, J. A., Kraus, W. E., & Tanner, C. J. (2015)
Mecanismos Fisiopatológicos Envolvidos no Desenvolvimento da Esteatohepatite Não Alcoólica
de Sousa, A. W. P., de Araújo, M. S. T., & Henriques, M. S. D. M. (2015)
The anti-obesogenic effects of nitric oxide.
Sansbury, B. E. (2014) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/1262
Arginine and Conjugated Linoleic Acid Reduce Fat Mass in Rats
Nall, J. L. (2010) · OakTrust (Texas A&M University Libraries)
Alencar, A. P. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2016.tde-25022016-160833
Evaluating Effect of Nitric Oxide Synthase Inhibitors on Adipocyte Formation
Titilayo, O. E., Eluwole, O. O., Esan, A. J., & O, O. C. T. (2014) · IOSR Journal of Pharmacy and Biological Sciences · doi:10.9790/3008-09552329
“Studies carried out on genetically obese and diabetic rodent models indicated that there was high expression of iNOS protein in adipose tissue and skeletal muscle compared with lean non-obese wild-types (16).”
BackgroundSt-Amand, E. (2015) · Corpus Université Laval (Université Laval)
Targeting obesity-related inflammation through nutritional and genetic approaches
LeMieux, M. J. (2015) · ThinkTech (Texas Tech University)
de Miranda, M. S., Leite, J. A., & de Araújo, M. S. T. (2014)
Subramanian, S., Pallati, P. K., Sharma, P., Agrawal, D. K., & Nandipati, K. C. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02365-1
RetractedThe role of the nitric oxide synthases in brain ischemia during carotid endarterectomy
Bogdanović, N., Obradovic, M. M., Jasnić, N., Spremo‐Potparević, B., Unic-Stojanovic, D. R., Radak, Đ., & Isenović, E. R. (2015) · Medicinska istrazivanja · doi:10.5937/medist1501040b
The role of the liver in glucose and lipid metabolism in obesity
Stanimirović, J., Obradovic, M. M., Gluvic, Z. M., & Isenović, E. R. (2018) · Medicinska istrazivanja · doi:10.5937/medist1803001s
(2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000235329.84906.3b
Therapeutic Management of Type 2 Diabetes: The Nitric Oxide Axis
Ranjbar, T., O’Connor, J. L., & Kashfi, K. (2022) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815079814122010013
Guimarães, J. P. T. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2021.tde-04052022-144336
Park, C. H., Noh, J. S., Jeon, J. P., & Yokozawa, T. (2023) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2022.01097
Kakimoto, P. A. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2021.tde-10082023-115406
Metadata
- Authors
- Fujimoto, M., Shimizu, N., Kunii, K., Martyn, J. A. J., Ueki, K., & Kaneki, M.
- Affiliations
- Harvard University (US)
- The University of Tokyo (JP)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2005-05-01
- Volume
- 54
- Issue
- 5
- Pages
- 1340-1348
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2138266804
- Cited by
- 209
- References
- 47
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 6 · 2023: 5 · 2022: 6 · 2021: 11 · 2020: 9 · 2019: 15 · 2018: 12 · 2017: 10 · 2016: 10 · 2015: 24 · 2014: 14 · 2013: 7 · 2012: 15
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Shriners Hospitals for Children
- National Institutes of Health
- National Institute of General Medical Sciences (R01GM055082, R01GM031569, R01GM061411)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058127)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- inducible nitric oxide synthase, fasting hyperglycemia, hepatic insulin resistance, insulin signaling, IRS-1, insulin receptor substrate 2, L-NIL, ob/ob mice, obesity, type 2 diabetes, nitric oxide, chronic inflammation, hepatocytes
- MeSH terms
- Animals, Cells, Cultured, Diabetes Mellitus, Type 2, Enzyme Inhibitors, Fasting, Hyperglycemia, Insulin, Insulin Resistance, Liver, Lysine, Male, Mice, Obese, Signal Transduction, Nitric Oxide Synthase, Phosphatidylinositol 3-Kinases, Nitric Oxide Donors, Hepatocytes, Mice, Nitric Oxide Synthase Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
